Back

Pre-reperfusion dapagliflozin does not reduce infarct size in STt-elevation myocardial infarction: a randomized controlled trial

30 August 2026 (14:05 - 14:15)
Organised by: Logo
Congress Presentation Part of: Primary percutaneous coronary intervention in STEMI: new strategies to improve reperfusion and outcomes ST-Elevation Myocardial Infarction (STEMI) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Krit Leemasawat

Chiang Mai University, Chiang Mai (Thailand)

5 More presentations in this session

Presentation thumbnail
Clinical study on the efficacy and safety of ketotifen in STEMI patients undergoing primary PCI
Mr P. Xie (Beijing, CN)
Abstract
Presentation thumbnail
Early use of roxadustat in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: a randomised clinical trial
Doctor Y. Wang (Shanghai, CN)
Abstract
Presentation thumbnail
Timing matters: impact of early oral p2y12 pretreatment on ischemic outcomes and reperfusion in stemi patients undergoing primary pci
Mr A. Gasca (Cali, CO)
Abstract
Presentation thumbnail
Bivalirudin versus heparin in high and low bleeding risk patients undergoing primary PCI for STEMI: pre-specified analysis from the BRIGHT-4 trial
Professor M. Qiu (Shenyang, CN)
Abstract
Presentation thumbnail
Immediate versus staged complete revascularization in ST-segment elevation myocardial infarction and multivessel disease with complex coronary anatomy: Insights from the OPTION-STEMI trial
Professor M. Kim (Gwangju, KR)
Abstract

Access the full session

Session thumbnail
Primary percutaneous coronary intervention in STEMI: new strategies to improve reperfusion and outcomes

The Event

Event poster

ESC Congress 2026

30 August 2026 14:05 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of dapagliflozin in non-diabetic patients with anterior wall ST-segment elevation acute myocardial infarction
15 March 2025
thumbnail
Congress Presentation
Interference with NLRP3-inflammasome mediated signaling does not reduce myocardial ischemia reperfusion injury in a pig model of myocardial infarction
30 June 2021
thumbnail
Congress Presentation
Cardioprotective strategy in ST-elevation acute myocardial infarction patients after reperfusion with percutaneous coronary intervention
28 August 2020
thumbnail
Congress Presentation
Infarct size following loading with ticagrelor/prasugrel versus clopidogrel in ST-segment elevation myocardial infarction
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources